A recent report published by
Infinium Global Research on autism spectrum disorder therapeutics market
provides an in-depth analysis of segments and sub-segments in the global as
well as regional autism spectrum disorder therapeutics market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional autism spectrum disorder therapeutics market over the short
term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of global autism spectrum disorder therapeutics
market. According to the report, the global autism spectrum disorder
therapeutics market is projected to grow at a CAGR of 4.4% over the forecast
period of 2019-2025.
The report on global autism
spectrum disorder therapeutics market covers segments such as drug class,
product type, and distribution channel. On the basis of drug class, the
sub-markets include insomnia drugs, selective serotonin reuptake inhibitors
(SSRIs), anticonvulsants, antipsychotics, and others. On the basis of product
type, the sub-markets include aripiprazole, risperidone, melatonin, CM-AT,
bumetanide, and balovaptan. On the basis of distribution channel, the
sub-markets include hospitals, retail pharmacies, and online channels.
The report provides profiles of
the companies in the market such as Pediatric Bioscience, Inc., Janssen
Pharmaceuticals, Inc., Curemark, Actavis, Inc., Teva Pharmaceutical Industries
Ltd., Mylan Pharmaceuticals, Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb,
and Merck & Co., Inc.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of autism spectrum disorder therapeutics market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.